Once we confirmed the positive correlations between STMN1 mRNA expression to FOXM1, MELK, CDK1, and CDK2, we validated the STMN1 overexpression in advanced ACC and the association with shorter disease-specific survival from the E-TABM-311 cohort. This evidence concerns the gene CDK2 and adrenal cortex carcinoma.